Clinical trial
Effects of Pentazocine Versus Lorazepam on Manic Symptoms
NCT00431184 · Mclean Hospital, Other · Completed
Key facts
| NCT number | NCT00431184 |
|---|---|
| Title | Effects of Pentazocine Versus Lorazepam on Manic Symptoms |
| Official title | Effects of Pentazocine Versus Lorazepam on Manic Symptoms |
| Lead sponsor | Mclean Hospital, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Schizoaffective Disorder, Manic Disorder, Mania, Manic State |
| Intervention type | Drug |
| Interventions | Pentazocine, Lorazepam |
| Enrollment | 19 |
| Start date | Jan 1, 2007 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Feb 5, 2007 |
| Last update posted | Mar 6, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: